Skip to main content
main-content

Obesity

23-09-2022 | EASD 2022 | Conference coverage | News

​​​​​​​ReTUNE analysis backs ‘personal fat threshold’ concept

The findings of the ReTUNE study show that losing a substantial amount of weight can reverse type 2 diabetes even in people who are only mildly overweight.

23-09-2022 | EASD 2022 | Conference coverage | News

Childhood body size modifies diabetes risk in adulthood

The highest risk for type 2 diabetes occurs in people who progress from a low body size in childhood to a high body size in adulthood, shows an analysis of data from the UK Biobank.

12-08-2022 | Metabolic surgery | News

Use of sleeve gastrectomy may be valid for some people with class 1 obesity

Study findings published in JAMA Network Open suggest that for people with class 1 obesity, sleeve gastrectomy is associated with greater weight loss and diabetes remission than lifestyle intervention, but the procedure is also linked to increased incidence of substance use disorder and self-harm.

05-08-2022 | Obesity | News

Endoscopic sleeve gastroplasty MERITs consideration for mild-to-moderate obesity

People with mild-to-moderate obesity who undergo minimally invasive endoscopic sleeve gastroplasty in addition to lifestyle intervention achieve greater weight loss and metabolic improvements than those undergoing lifestyle modification alone, show the MERIT trial results.

Syringe and glucometer on a table - blood sugar in diabetes concept

14-06-2022 | Pathogenesis | News

People with ‘low BMI diabetes’ have a unique metabolic profile

Researchers have characterized an atypical form of diabetes in Indian men with low BMI, which has a unique metabolic profile setting it apart from type 1 and type 2 diabetes.

05-06-2022 | ADA 2022 | Conference coverage | News

Almost any liver fat may be abnormal

Researchers report that metabolic abnormalities begin to increase at levels of liver fat commonly regarded as normal.

Person standing on weigh scales with tape measure in foreground

04-06-2022 | ADA 2022 | Conference coverage | News

​​​​​​​SURMOUNT-1 places tirzepatide weight loss efficacy within surgical range

A weekly injection of tirzepatide results in a substantial bodyweight reduction over and above that achieved with lifestyle intervention in people with obesity, show the SURMOUNT-1 findings.

04-06-2022 | ADA 2022 | Conference coverage | News

Adolescent obesity may trigger type 1 diabetes

A nationwide population-based study reveals a link between obesity in adolescence and an increased risk for type 1 diabetes in young adulthood.